Where is AM-Pharma headquartered?

AM-Pharma is located in Utrecht, utrecht.

Who invested in AM-Pharma?

AM-Pharma has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for AM-Pharma?

AM-Pharma closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

am-pharma.com

AM-Pharma

AM-Pharma develops human alkaline phosphatase therapeutics for the treatment of acute kidney injury.

Business Model:

Revenue: $31.4M

Employees: 11-50

Geographic Data

Address: Stadsplateau 6

City: Utrecht

State: utrecht

Zip: 3521

Country: NL

Financial Info

Stage:

debt financing

Raised Last:

$26M

Raised Total:

$242M

Social

Crunchbase

Metrics

6,367,703Website Global Rank

1,088Website Monthly Traffic

Twitter Followers

Description

AM-Pharma develops human alkaline phosphatase therapeutics for the treatment of acute kidney injury.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
3/2020	Seed Round	1	-	Eurazeo Eurazeo
9/2011	Series D		$39.8M	Ysios Capital Kurma Partners BB Biotech Ventures IDInvest Partners
3/2020	Venture Round	8	$25.4M	Andera Partners BB Biotech Ventures Cowen Healthcare Investments Forbion Capital Partners Gilde Healthcare Idinvest Partners Kurma Partners Ysios Capital Andera Partners BB Biotech Ventures Cowen Healthcare Investments Forbion Capital Partners Gilde Healthcare Idinvest Partners Kurma Partners Ysios Capital
8/2007	Series C	2	$3.4M	Forbion Capital Partners Inventages Venture Capital Investment Inc. Forbion Capital Partners Inventages Venture Capital Investment Inc.
9/2011	Series D	4	$39.9M	Kurma Partners Ysios Capital Idinvest Partners BB Biotech Ventures Kurma Partners Ysios Capital
9/2014	Series E	6	$15.8M	Gilde Healthcare Kurma Partners AbbVie Biotech Ventures BB Biotech Ventures Inventages Venture Capital Investment Inc. Ysios Capital Gilde Healthcare Kurma Partners
7/2019	Series F	8	$130.1M	Andera Partners Life Sciences Partners Ysios Capital Pureos Bioventures Kurma Partners Idinvest Partners Gilde Healthcare Forbion Capital Partners Andera Partners Life Sciences Partners
5/2015	Equity		$87.5M	Pfizer
8/2001	Series A	1	$569.5k	Biopartners Capital Biopartners Capital
8/2011	Venture Round	1	-	Idinvest Partners Idinvest Partners
3/2020	Debt Financing	1	$26.5M	European Investment Bank European Investment Bank
5/2015	Corporate Round	1	-	Pfizer Pfizer
7/2019	Series E		$130.7M	Andera Partners LSP Forbion Ysios Capital Kurma Partners ID Invest Partners BB Pureos Bioventures Gilde Healthcare
2/2002	Series B	2	-	ABN AMRO Fund Biopartners Capital ABN AMRO Fund Biopartners Capital
9/2014	Series E		$15.7M	Gilde Healthcare Partners AbbVie BB Biotech Ventures IDInvest Partners Inventages Ysios Capital
3/2020	Seed Round	1	-	Eurazeo Eurazeo
5/2015	Corporate Round	1	-
8/2011	Venture Round	1	-	Idinvest Partners Idinvest Partners
2/2002	Series B	2	-	ABN AMRO Fund ABN AMRO Fund

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details